|
Volumn 52, Issue 2, 2009, Pages 514-523
|
Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer.
a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 ((R) 2 METHYLPYRROLIDIN 2 YL) 1H BENZIMIDAZOLE 4 CARBOXAMIDE;
2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE;
ANTINEOPLASTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
TEMOZOLOMIDE;
ANIMAL;
AREA UNDER THE CURVE;
ARTICLE;
BIOAVAILABILITY;
DOG;
DRUG ANTAGONISM;
EXPERIMENTAL MELANOMA;
FEMALE;
HAPLORHINI;
HUMAN;
MOUSE;
MOUSE MUTANT;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PATHOLOGY;
RAT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
AREA UNDER CURVE;
BENZIMIDAZOLES;
BIOLOGICAL AVAILABILITY;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOGS;
ENZYME INHIBITORS;
FEMALE;
HAPLORHINI;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, SCID;
POLY(ADP-RIBOSE) POLYMERASES;
RATS;
|
EID: 60549117554
PISSN: None
EISSN: 15204804
Source Type: Journal
DOI: 10.1021/jm801171j Document Type: Article |
Times cited : (247)
|
References (0)
|